Azitra, Inc.
AZTR- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001701478
No open-market purchases or sales by Azitra, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $3.63M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Azitra, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +7 vs. Q1 2026
- Shares held
- 21.6M
- +21.1M (+3,902.2%) vs. Q1 2026
- Total value
- $3.63M
- +$3.50M (+2,770.2%) vs. Q1 2026
- New holders
- 8
- 5 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AZTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $3.63M |
| Q1 2026 | 7 | $126.5K |
| Q4 2025 | 9 | $59.7K |
| Q3 2025 | 5 | $29.3K |
| Q2 2025 | 6 | $105.0K |
| Q1 2025 | 11 | $160.8K |
| Q4 2024 | 10 | $109.0K |
| Q3 2024 | 7 | $74.9K |
| Q2 2024 | 8 | $58.5K |
| Q1 2024 | 12 | $316.2K |
| Q4 2023 | 5 | $43.5K |
| Q3 2023 | 8 | $273.4K |
| Q2 2023 | 4 | $495.6K |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Azitra, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 11,292,186 | $1.89M | 3.28% | +11,291,186+1,129,118.6% | Added |
| Stonepine Capital Management, LLC | 5,285,476 | $886.9K | 0.68% | +5,285,476 | New |
| Nantahala Capital Management, LLC | 4,427,226 | $742.9K | 0.02% | +4,427,226 | New |
| Jane Street Group, LLC | 248,433 | $41.7K | 0.00% | +248,433 | New |
| Geode Capital Management, LLC | 95,409 | $16.0K | 0.00% | −374,469−79.7% | Reduced |
| Citadel Advisors LLC | 86,242 | $14.5K | 0.00% | +86,242 | New |
| Virtu Financial LLC | 64,940 | $11.0K | 0.00% | +64,940 | New |
| UBS Group AG | 50,481 | $8.48K | 0.00% | +20,276+67.1% | Added |
| StoneX Group Inc. | 28,651 | $5.03K | 0.00% | +6,187+27.5% | Added |
| Tower Research Capital LLC (TRC) | 19,500 | $3.27K | 0.00% | +4,415+29.3% | Added |
| CI Private Wealth, LLC | 14,451 | $2.43K | 0.00% | +14,451 | New |
| Susquehanna International Group, LLP | 12,237 | $2.05K | 0.00% | +12,237 | New |
| Citigroup Inc | 6,149 | $1.03K | 0.00% | +4,444+260.6% | Added |
| Barclays PLC | 1 | $0 | 0.00% | +1 | New |
| FMR LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |